CME Group (NASDAQ:CME) Issues Earnings Results

CME Group (NASDAQ:CME) announced its quarterly earnings data on Wednesday. The financial services provider reported $1.38 earnings per share for the quarter, missing analysts’ consensus estimates of $1.41 by ($0.03), MarketWatch Earnings reports. CME Group had a net margin of 46.39% and a return on equity of 9.93%. During the same period last year, the business earned $1.90 earnings per share.

NASDAQ:CME opened at $149.99 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $53.79 billion, a PE ratio of 22.62, a P/E/G ratio of 5.09 and a beta of 0.32. CME Group has a fifty-two week low of $131.80 and a fifty-two week high of $225.36. The company has a fifty day moving average of $166.35 and a two-hundred day moving average of $172.99.

In related news, Director Daniel R. Glickman sold 900 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $173.22, for a total transaction of $155,898.00. Following the completion of the sale, the director now directly owns 14,405 shares in the company, valued at $2,495,234.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Charles P. Carey sold 8,000 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $165.39, for a total value of $1,323,120.00. In the last quarter, insiders sold 15,900 shares of company stock worth $2,695,838. Company insiders own 1.20% of the company’s stock.

CME has been the topic of several research reports. Loop Capital started coverage on shares of CME Group in a report on Friday, September 11th. They issued a “sell” rating and a $138.00 price target on the stock. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating and set a $175.00 price objective on the stock in a research note on Tuesday, September 29th. BidaskClub cut shares of CME Group from a “sell” rating to a “strong sell” rating in a report on Wednesday. Atlantic Securities raised shares of CME Group from a “neutral” rating to an “overweight” rating and upped their price target for the company from $176.00 to $195.00 in a report on Wednesday, September 23rd. Finally, Oppenheimer reiterated a “buy” rating on shares of CME Group in a research note on Wednesday, July 29th. Five research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $182.29.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Cost of Debt

Earnings History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.